New Guidelines for the Treatment of Cardiogenic Shock
The U.S. Food and Drug Administration (FDA) has determined Impella is safe and effective for its intended uses.
-
1,500+
Peer reviewed clinical studies have published on Impella, including DanGer Shock RCT published in the New England Journal of Medicine
-
17
Clinical Guidelines and Consensus statements
-
330,000+
Patients have been treated with Impella heart pumps
DanGer Shock Results from Jacob Møller, M.D.
Jacob Møller, M.D., the principal investigator of the DanGer Shock trial, discusses study results he presented at the 2024 American College of Cardiology (ACC) Scientific Session in this interview with Abiomed's Chief Medical Officer Chuck Simonton, M.D.
For Interventional Cardiologists
Treat high-risk PCI, cardiogenic shock and right heart failure patients
For Cardiac and Vascular Surgeons
Escalate, stabilize and recover native organs with minimally-invasive surgical techniques
For Nurses
Use calculators, watch quick skills videos and learn patient management best practices
For Fellows
Advance your knowledge and develop skills to treat complex PCI patients
For Referring Providers
Are you caring for patients with heart disease? Learn more about how Impella heart pumps work, the benefits of Protected PCI with Impella and explore patient identification resources.
References
- Møller, J., et al. (2024). Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med.
- Abiomed. (2024, September 13). Retrieved from PubMed search: “(Impella) AND ("Impella"[All Fields] AND 2000/01/01:2024/09/12[epdat]).
- Lawton, J. S. et al. (2021). 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. https://doi.org/10.1161/CIR.0000000000001038
- Chieffo, A. et al. (2021). 2021 Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. EuroIntervention. https://eurointervention.pcronline.com/doi/10.4244/EIJY21M05_01
- Riley, R. et al. (2020). 2020 SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease. Catheter Cardiovasc Interv. DOI: 10.1002/ccd.28994
- Amsterdam, E. et al. (2014). 2014 Guideline for the Management of Patients with non-ST elevation ACS. Circulation. DOI: 10 .1161 /CIR .0000000000000134
- O'Gara, P. et al. (2013). 2013 ACCF/AHA Guideline for the Management of STEMI. Circulation. http://dx.doi.org/10.1016/j.jacc.2012.11.019
- Levine, G. et al. (2011). 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. J Am Coll Cardiol. doi:10.1016/j.jacc.2011.08.007
- Bernhardt, A. et al. (2023). 2023 ISHLT/ HFSA Guidelines on Acute MCS. J Heart and Lung Transplantation https://doi.org/10.1016/j.healun.2022.10.028.
- Heidenreich, P. et al. (2022). 2022 AHA/ACC/HFSA Guideline for Management of HF. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2021.12.012
- McDonagh, T. et al. (2021). 2021 ESC Guidelines Acute and Chronic Heart Failur. Eur Heart J. doi:10.1093/eurheartj/ehab368
- Chieffo, A. et al. (2021). 2021 EAPCI/ACVC Expert Consensus on pVAD. EuroIntervention. DOI: 10.4244/EIJY21M05_01
- Lorusso, R. et al. (2020). 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezaa283
- Cronin, E. et al. (2019). 2019 HRS/EHRA/APHRS?LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. doi:10.1093/ejcts/ezaa283
- Peura, J. et al. (2012). Recommendations for the use of MCS. Circulation. doi:10.1093/ejcts/ezaa283
- Tamis-Holland, J. et al. (2024) SCAI Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI. JSCAI. https://www.jscai.org/article/S2772-9303(24)01740-X/fulltext
- Vrints, C. et al. (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. EHJ. https://academic.oup.com/eurheartj/article/45/36/3415/7743115?login=false
- Schäfer, A. et al. (2024) Consensus Statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention; 20:e1-e14 DOI: 10.4244/EIJ-D-23-01100
- 17. Rao, SV, et al. (2025). ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. https://pubmed.ncbi.nlm.nih.gov/40013746/
NPS-1309